Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06506669 · ClinicalTrials.gov registry record · NA

Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study

A NA study of Cataract and Anesthesia, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06506669: Active NA study of Cataract and Anesthesia, sponsored by University of California, San Francisco.

NCT06506669 is a NA study of Cataract and Anesthesia that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06506669, a NA study of Cataract and Anesthesia, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot clinical trial comparing two different sedation approaches for cataract surgery is to assess patient satisfaction, the quality of recovery, and surgical outcomes as well as to evaluate the overall feasibility and acceptability of the study protocol for the purpose of planning a larger clinical trial. Participants will be asked to respond to several surveys throughout the study on their experience and to assess outcomes of interest.

Primary Outcome

The Iowa Satisfaction with Anesthesia Scale (ISAS) is an 11-item validated questionnaire assessing patient satisfaction with anesthesia care. Each item is scored from -3 to +3, and the total score is calculated as the mean of all items, resulting in a total score range of -3 to +3. Higher scores indicate greater satisfaction. For this analysis, high satisfaction is defined as an ISAS score ≥ 2.

Interventions

  • PROCEDURE Placebo
  • PROCEDURE Oral sedation

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-06-12
Est. Completion 2025-08
Phase NA

What the registry record for NCT06506669 still lists

NCT06506669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (91% lower).

The record links to 4 conditions, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06506669 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06506669 about?

NCT06506669 is a clinical study titled "Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study". The goal of this pilot clinical trial comparing two different sedation approaches for cataract surgery is to assess patient satisfaction, the quality of recovery, and surgical outcomes as well as to evaluate the overall feasibility and acceptability of the study protocol for the purpose of planning ...

What is the current status of trial NCT06506669?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-06-12. Estimated completion is 2025-08.

What conditions does trial NCT06506669 study?

This clinical trial studies the following conditions: Cataract, Anesthesia, Patient Satisfaction, Bilateral Senile Cataract.

What interventions are being tested in trial NCT06506669?

The interventions under investigation include: Placebo (PROCEDURE), Oral sedation (PROCEDURE).

Who is sponsoring clinical trial NCT06506669?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06506669 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06506669's enrollment target sits among peer trials

20 79th of 83 higher than 2 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06506669, the US trial registry maintained by the National Library of Medicine. NCT06506669 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.